Management of hypertension in overweight and obese patients: a practical guide for clinicians (Q36255407)

13 August 2017

1 reference

title

Management of hypertension in overweight and obese patients: a practical guide for clinicians (English)

1 reference

13 August 2017

0 references

3

James D Douketis

1 reference

13 August 2017

2

Arya M Sharma

1 reference

13 August 2017

Francesco Dentali

1

1 reference

13 August 2017

1 October 2005

1 reference

Current Hypertension Reports

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

5

1 reference

13 August 2017

330-336

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-005-0065-5

13 August 2017

0 references

cites work

Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-005-0065-5

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-005-0065-5

Differential Control of Systolic and Diastolic Blood Pressure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-005-0065-5

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

12 December 2020

Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program

1 reference

12 December 2020

The disease burden associated with overweight and obesity

1 reference

12 December 2020

A randomized trial of a low-carbohydrate diet for obesity

1 reference

12 December 2020

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

1 reference

12 December 2020

Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension

1 reference

12 December 2020

Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

12 December 2020

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Drug Treatment of Hypertension in Patients With Diabetes Mellitus

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Effect of doxazosin on insulin resistance in hypertensive patients with obesity

1 reference

12 December 2020

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

12 December 2020

Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension

1 reference

12 December 2020

Prevalence of attempting weight loss and strategies for controlling weight

1 reference

12 December 2020

Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results

1 reference

12 December 2020

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

12 December 2020

Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

1 reference

12 December 2020

New developments in mechanisms of obesity-induced hypertension: role of adipose tissue

1 reference

12 December 2020

Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails

1 reference

12 December 2020

Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure.

1 reference

12 December 2020

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

1 reference

12 December 2020

A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction

1 reference

12 December 2020

Preservation of renal function: the spectrum of effects by calcium-channel blockers

1 reference

12 December 2020

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

12 December 2020

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

1 reference

12 December 2020

Oral clonidine premedication decreases energy expenditure in human volunteers.

1 reference

12 December 2020

Obesity as a chronic disease: modern medical and lifestyle management

1 reference

12 December 2020

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

1 reference

12 December 2020

Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension

1 reference

12 December 2020

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

1 reference

12 December 2020

1 reference

12 December 2020

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

12 December 2020

The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study

1 reference

12 December 2020

Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients

1 reference

12 December 2020

10.1007/S11906-005-0065-5

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16157073